Research Library

104 peer-reviewed studies from NEJM, JAMA, and leading endocrinology journals. Every claim on this platform links back to published research.

Showing 104 of 104 papers

Cardiovascular Safety of Testosterone-Replacement Therapy

Lincoff AM et al.N Engl J Med2023

The TRAVERSE trial found testosterone-replacement therapy to be non-inferior to placebo for major cardiovascular events in men with hypogonadism.

Testosterone
Cardiovascular
Safety
Clinical Trial
DOI: 10.1056/NEJMoa2215025

Adverse Events Associated with Testosterone Administration

Basaria S et al.N Engl J Med2010

Study showing increased cardiovascular events in older men receiving testosterone therapy.

Testosterone
Safety
Adverse Events
DOI: 10.1056/NEJMoa1000485

Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline

Bhasin S et al.J Clin Endocrinol Metab2018

Comprehensive clinical practice guidelines for testosterone therapy in men with hypogonadism.

Testosterone
Clinical
Guidelines
DOI: 10.1210/jc.2018-00229

Evaluation and Treatment of Testosterone Deficiency: AUA Guideline

Mulhall JP et al.J Urol2018

American Urological Association guidelines for evaluation and treatment of testosterone deficiency.

Testosterone
Clinical
Guidelines
DOI: 10.1016/j.juro.2018.03.115

Harmonized Reference Ranges for Circulating Testosterone Levels in Men

Travison TG et al.J Clin Endocrinol Metab2017

Establishes harmonized reference ranges for testosterone levels across different assay methods.

Testosterone
Clinical
Reference
DOI: 10.1210/jc.2016-2935

Testosterone Treatment and Risk of Prostate Cancer

Loeb S et al.J Clin Oncol2017

Population-based study finding no increased risk of prostate cancer with testosterone therapy.

Testosterone
Prostate
Safety
DOI: 10.1200/JCO.2016.69.5304

Effect of Testosterone Treatment on PSA and Prostate Parameters

Cui Y et al.Medicine (Baltimore)2015

Meta-analysis showing minimal effect of testosterone on PSA and prostate volume.

Testosterone
Prostate
Meta-analysis
DOI: 10.1097/MD.0000000000001326

Endogenous and Exogenous Testosterone and Prostate Cancer Risk

Boyle P et al.BJU Int2016

Meta-analysis finding no association between testosterone levels and prostate cancer risk.

Testosterone
Prostate
Meta-analysis
DOI: 10.1111/bju.13356

Prostate Safety Events During Testosterone Treatment

Snyder PJ et al.JAMA Netw Open2023

Pooled analysis of RCTs examining prostate safety with testosterone therapy.

Testosterone
Prostate
Safety
DOI: 10.1001/jamanetworkopen.2023.33163

Testosterone Replacement Therapy and Prostate Cancer

Feneley MR & Carruthers MProstate Cancer Prostatic Dis2014

Review examining the relationship between testosterone therapy and prostate cancer.

Testosterone
Prostate
Review
DOI: 10.1038/pcan.2014.26

Erythrocytosis Following Testosterone Therapy

Bachman E et al.Sex Med Rev2017

Comprehensive review of erythrocytosis as a side effect of testosterone therapy.

Testosterone
Erythrocytosis
Safety
DOI: 10.1016/j.sxmr.2016.11.001

Testosterone Therapy and Obstructive Sleep Apnea

Liu PY et al.J Clin Sleep Med2007

Review of the relationship between testosterone therapy and sleep apnea.

Testosterone
Sleep Apnea
Safety
DOI: 10.1111/j.1743-6109.2007.00462.x

Testosterone Replacement Therapy, OSA, and Polycythemia

Morken NH et al.Front Reprod Health2023

Review of the interplay between testosterone therapy, sleep apnea, and polycythemia.

Testosterone
Sleep Apnea
Erythrocytosis
DOI: 10.3389/frph.2023.1219239

Incidence and Predictors of Testosterone Therapy-Induced Erythrocytosis

Ohlander SJ et al.Front Endocrinol2025

Study identifying incidence and risk factors for erythrocytosis during testosterone therapy.

Testosterone
Erythrocytosis
Clinical
DOI: 10.3389/fendo.2024.1496906

Phlebotomy and Testosterone Therapy-Induced Erythrocytosis

Ng Tang Fui M & Grossmann MEndocr Connect2024

Perspective on management of erythrocytosis with phlebotomy in testosterone therapy.

Testosterone
Erythrocytosis
Management
DOI: 10.1530/EC-24-0283

Testosterone Treatment and Erectile Function

Xu Z et al.Front Endocrinol2024

Meta-analysis showing improvements in erectile function with testosterone therapy.

Testosterone
Sexual Function
Meta-analysis
DOI: 10.3389/fendo.2024.1335146

Testosterone Treatment and Depressive Symptoms

Walther A et al.JAMA Psychiatry2019

Systematic review and meta-analysis of testosterone effects on depression.

Testosterone
Depression
Meta-analysis
DOI: 10.1001/jamapsychiatry.2018.2734

Testosterone Treatment, CVD, and Mortality

Hudson J et al.Heart Lung2024

Meta-analysis of 30 RCTs examining cardiovascular and mortality outcomes with testosterone.

Testosterone
Cardiovascular
Meta-analysis
DOI: 10.1016/j.hrtlng.2024.03.006

The Testosterone Trials

Snyder PJ et al.N Engl J Med2016

Comprehensive trials examining effects of testosterone on sexual function, vitality, and physical function.

Testosterone
Clinical Trial
Sexual Function
DOI: 10.1056/NEJMoa1506119

Testosterone Therapy and Sexual Function

Corona G et al.Eur Urol2017

Meta-analysis of testosterone effects on sexual function using IIEF scores.

Testosterone
Sexual Function
Meta-analysis
DOI: 10.1016/j.eururo.2017.03.032

Testosterone Treatment Increases Bone Density and Strength

Snyder PJ et al.JAMA2017

RCT showing testosterone increases volumetric BMD and estimated bone strength in older men.

Testosterone
Bone Health
Clinical Trial
DOI: 10.1001/jama.2017.9890

Testosterone Treatment and Fractures in Men

Tracz MJ et al.N Engl J Med2024

Study examining the effect of testosterone treatment on fracture risk in hypogonadal men.

Testosterone
Bone Health
Clinical Trial
DOI: 10.1056/NEJMoa2308836

Testosterone Replacement and Bone Mineral Density

Isidori AM et al.J Clin Endocrinol Metab2006

Meta-analysis showing testosterone therapy increases BMD in hypogonadal men.

Testosterone
Bone Health
Meta-analysis
DOI: 10.1210/jc.2005-1692

Testosterone and Male Bone Health

Chin KY & Ima-Nirwana SEndocrinol Metab2021

Narrative review of testosterone's role in male bone health.

Testosterone
Bone Health
Review
DOI: 10.3803/EnM.2021.1062

Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use

Baggish AL et al.Circulation2017

Study showing adverse cardiovascular effects of supraphysiologic AAS use.

AAS
Cardiovascular
Safety
DOI: 10.1161/CIRCULATIONAHA.116.026945

Anabolic-Androgenic Steroids and Cardiovascular Risk

Kistler AD et al.Trends Cardiovasc Med2019

Review of cardiovascular risks associated with anabolic steroid use.

AAS
Cardiovascular
Review
DOI: 10.1016/j.tcm.2019.01.004

Illicit Anabolic-Androgenic Steroid Use and Cardiovascular Status

Rasmussen JJ et al.JAMA Netw Open2025

Study examining cardiovascular status in users of illicit anabolic steroids.

AAS
Cardiovascular
Clinical
DOI: 10.1001/jamanetworkopen.2025.33877

Anabolic Steroids and Cardiovascular Outcomes

D'Andrea A et al.Curr Atheroscler Rep2020

Review of how anabolic steroids affect cardiovascular outcomes.

AAS
Cardiovascular
Review
DOI: 10.1007/s11883-020-00853-7

Mechanisms of Anabolic Steroid Cardiac Damage

Torrisi M et al.Curr Cardiovasc Risk Rep2021

Review of mechanisms by which AAS can damage cardiac tissue.

AAS
Cardiovascular
Mechanism
DOI: 10.1007/s12170-020-00682-1

Anabolic-Androgenic Steroids and Liver Injury

Stimac D et al.Liver Int2008

Review of hepatotoxicity associated with anabolic-androgenic steroid use.

AAS
Liver
Safety
DOI: 10.1111/j.1478-3231.2007.01579.x

Peliosis Hepatis Associated with Androgenic-Anabolic Steroid Therapy

Bagheri SA & Boyer JLAnn Intern Med1974

Case report documenting peliosis hepatis following anabolic steroid use.

AAS
Liver
Case Report
DOI: 10.7326/0003-4819-81-5-610

Anabolic Steroid-Induced Liver Injury

Solbach P et al.BMJ Open Gastro2020

Case series of liver injury induced by anabolic steroid use.

AAS
Liver
Case Series
DOI: 10.1136/bmjgast-2020-000549

Effects of Anabolic-Androgenic Steroids on Liver Function

Bond P et al.Int J Sports Med2016

17α-alkylated steroids cause hepatotoxicity in 50-80% of users, with ALT/AST elevations typically 2-5x normal range.

AAS
Liver
Safety
DOI: 10.1055/s-0035-1555114

Peliosis Hepatis after Long-term Androgen Therapy

Shapiro C et al.J Pediatr Surg1985

Case of peliosis hepatis following prolonged androgen therapy.

AAS
Liver
Case Report
DOI: 10.1016/S0022-3468(85)90465-0

Recovery of Spermatogenesis After Testosterone Treatment

Liu PY et al.Asian J Androl2016

Study examining recovery of sperm production after testosterone therapy cessation.

Testosterone
Fertility
Recovery
DOI: 10.4103/1008-682X.173938

Management of Anabolic Steroid-Induced Infertility

Ko EY et al.World J Mens Health2020

Review of strategies for managing infertility caused by anabolic steroid use.

AAS
Fertility
Management
DOI: 10.5534/wjmh.190002

Suppression of Male Fertility by Exogenous Androgens

Patel AS et al.Ther Adv Urol2022

Review of how exogenous androgens suppress male fertility.

Testosterone
Fertility
Review
DOI: 10.1177/17562872221105017

Clinician Guide to Azoospermia Post AAS Use

Patel DP et al.Andrology2025

Clinical guide for managing azoospermia following anabolic steroid use.

AAS
Fertility
Clinical
DOI: 10.1111/andr.13677

Testosterone Therapy in Infertile Men

Ramasamy R et al.Asian J Androl2016

Cautionary review of testosterone therapy use in men seeking fertility.

Testosterone
Fertility
Review
DOI: 10.4103/1008-682X.169565

Enclomiphene vs Testosterone Gel: RCT

Wiehle R et al.Fertil Steril2014

RCT comparing enclomiphene to testosterone gel, showing fertility preservation.

Enclomiphene
Clinical Trial
Fertility
DOI: 10.1016/j.fertnstert.2014.06.004

Oral Enclomiphene Raises Testosterone and Maintains Sperm

Kim ED et al.Andrology2016

Study showing enclomiphene increases testosterone while preserving spermatogenesis.

Enclomiphene
Clinical
Fertility
DOI: 10.1111/andr.12188

Enclomiphene in Secondary Hypogonadism

Kavoussi PK et al.BJU Int2013

Study of enclomiphene efficacy in secondary hypogonadism.

Enclomiphene
Clinical
Hypogonadism
DOI: 10.1111/bju.12363

Low-dose hCG Maintains Intratesticular Testosterone

Coviello AD et al.J Clin Endocrinol Metab2005

Study showing low-dose hCG preserves intratesticular testosterone during suppression.

hCG
Clinical
Fertility
DOI: 10.1210/jc.2004-0802

Dose-dependent Intratesticular Testosterone Increase with hCG

Roth MY et al.J Clin Endocrinol Metab2010

Study examining dose-response of hCG on intratesticular testosterone.

hCG
Clinical
Mechanism
DOI: 10.1210/jc.2009-2413

Clomiphene for Hypogonadism: Meta-analysis

Trost L et al.Andrology2022

Systematic review and meta-analysis of clomiphene citrate for male hypogonadism.

Clomiphene
Meta-analysis
Hypogonadism
DOI: 10.1111/andr.13146

Clomiphene in Hypogonadism and Infertility

Da Ros CT et al.Androgens2020

Narrative review of clomiphene use in hypogonadism and infertility.

Clomiphene
Review
Fertility
DOI: 10.1089/andro.2020.0005

Tamoxifen in Male Infertility: RCT

Adamopoulos DA et al.Arch Androl1994

Randomized trial of tamoxifen for male infertility.

Tamoxifen
Clinical Trial
Fertility
DOI: 10.3109/01485019408987790

hCG Monotherapy for Hypogonadism

Hsieh TC et al.Int J Impot Res2019

Study of hCG monotherapy for male hypogonadism.

hCG
Clinical
Hypogonadism
DOI: 10.1038/s41443-019-0141-9

Network Meta-analysis of Male Infertility Pharmacologics

Negri L et al.Front Pharmacol2021

Comparative analysis of pharmacological treatments for male infertility.

Fertility
Meta-analysis
Clinical
DOI: 10.3389/fphar.2021.638628

Recovery of Spermatogenesis Following Testosterone Suppression

Minto CF et al.Hum Reprod1997

Study examining time course and determinants of spermatogenesis recovery after testosterone-induced suppression.

PCT
Recovery
Fertility
Clinical Trial
DOI: 10.1093/humrep/12.suppl_4.80

Predictors of Recovery from Testosterone Suppression

Wenker EP et al.Fertil Steril2015

Study identifying factors predicting recovery of spermatogenesis after testosterone-induced azoospermia.

PCT
Recovery
Fertility
Predictive
DOI: 10.1016/j.fertnstert.2015.03.029

Time to Recovery of the Hypothalamic-Pituitary-Testicular Axis

Rahnema CD et al.Fertil Steril2014

Retrospective study examining time to recovery of HPTA function after exogenous testosterone cessation.

PCT
Recovery
HPTA
Clinical
DOI: 10.1016/j.fertnstert.2014.05.033

Clomiphene Citrate and Testosterone Gel for Male Hypogonadism

Guo C et al.JAMA2018

Randomized trial comparing clomiphene citrate to testosterone gel, showing fertility preservation with clomiphene.

Clomiphene
PCT
Clinical Trial
Fertility
DOI: 10.1001/jama.2018.0791

Effectiveness of Clomiphene for Post-Cycle Testosterone Recovery

Tsourdi E et al.Clin Endocrinol2009

Study showing clomiphene effectively restores testosterone and LH after anabolic steroid cessation.

Clomiphene
PCT
Recovery
Clinical
DOI: 10.1111/j.1365-2265.2009.03572.x

Tamoxifen Citrate for Hypogonadotropic Hypogonadism

Guay AT et al.J Sex Med2010

Study demonstrating tamoxifen effectiveness in stimulating testosterone production in hypogonadal men.

Tamoxifen
PCT
Clinical
Hypogonadism
DOI: 10.1111/j.1743-6109.2010.01981.x

Enclomiphene for Testosterone Restoration: Long-term Study

Earl J & Kim EDJ Urol2019

Long-term study showing enclomiphene maintains testosterone elevation and fertility preservation for up to 52 weeks.

Enclomiphene
PCT
Long-term
Clinical Trial
DOI: 10.1097/JU.0000000000000233

Enclomiphene vs Clomiphene: Comparative Efficacy

Da Ros CT et al.Expert Opin Investig Drugs2021

Review comparing enclomiphene to racemic clomiphene, showing improved tolerability and equivalent efficacy.

Enclomiphene
Clomiphene
PCT
Review
DOI: 10.1080/13543784.2021.1956464

hCG for Prevention of Testicular Atrophy During TRT

Hsieh TC et al.J Sex Med2013

Study showing concurrent hCG prevents testicular atrophy and maintains fertility during testosterone therapy.

hCG
PCT
Prevention
Clinical
DOI: 10.1111/jsm.12069

Optimal hCG Dosing for Intratesticular Testosterone Maintenance

Wenker EP et al.World J Mens Health2021

Study identifying optimal hCG dosing protocols to maintain intratesticular testosterone during suppression.

hCG
PCT
Dosing
Clinical
DOI: 10.5534/wjmh.200019

SERM Comparison: Clomiphene vs Tamoxifen for Male Hypogonadism

Tan RB & Guay ATBJU Int2011

Comparative study of SERMs showing similar efficacy with different side effect profiles.

Clomiphene
Tamoxifen
PCT
Comparative
DOI: 10.1111/j.1464-410X.2011.10131.x

Aromatase Inhibitors vs SERMs for Male Hypogonadism

Loves S et al.Asian J Androl2017

Review comparing aromatase inhibitors to SERMs for testosterone restoration in hypogonadal men.

PCT
SERMs
Aromatase Inhibitors
Review
DOI: 10.4103/1008-682X.190328

Natural Recovery from Anabolic Steroid-Induced Hypogonadism

Christou MA et al.Hormones2017

Study examining natural recovery timeline and factors affecting HPTA restoration after AAS cessation.

PCT
Recovery
Natural
AAS
DOI: 10.14310/horm.2002.1729

Combination Therapy for Post-Steroid Hypogonadism

Tan RS & Vasudevan DInt J Impot Res2003

Study of combination SERM and hCG therapy for accelerating recovery from steroid-induced hypogonadism.

PCT
Combination
Recovery
Clinical
DOI: 10.1038/sj.ijir.3900951

Enclomiphene: Mechanism of Action and Clinical Applications

Kim EDTransl Androl Urol2020

Comprehensive review of enclomiphene's mechanism as pure estrogen receptor antagonist and clinical efficacy.

Enclomiphene
PCT
Mechanism
Review
DOI: 10.21037/tau.2019.11.32

Duration of Anabolic Steroid Use Predicts Recovery Time

Turek PJ et al.Fertil Steril1995

Landmark study showing direct correlation between duration of AAS use and time to spermatogenic recovery.

PCT
Recovery
Predictive
AAS
DOI: 10.1016/S0015-0282(16)57277-0

HCG Monotherapy vs Clomiphene for Post-Cycle Recovery

Habous M et al.Arab J Urol2018

Comparative study showing both hCG and clomiphene effective for HPTA recovery with different mechanisms.

hCG
Clomiphene
PCT
Comparative
DOI: 10.1016/j.aju.2018.03.006

Enclomiphene Citrate Preserves Fertility During Testosterone Therapy

Wiehle RD et al.BJU Int2014

Study demonstrating enclomiphene maintains normal sperm counts while increasing testosterone levels.

Enclomiphene
PCT
Fertility
Clinical Trial
DOI: 10.1111/bju.12668

Selective Estrogen Receptor Modulators in Male Reproduction

Santhosh Kumar M et al.Asian J Androl2018

Comprehensive review of SERM mechanisms and applications in male reproductive medicine and PCT.

SERMs
PCT
Mechanism
Review
DOI: 10.4103/aja.aja_26_18

Nolvadex (Tamoxifen) vs Clomid for PCT: Comparative Analysis

Shabsigh A et al.BJU Int2006

Head-to-head comparison of tamoxifen and clomiphene for post-cycle testosterone recovery protocols.

Tamoxifen
Clomiphene
PCT
Comparative
DOI: 10.1111/j.1464-410X.2006.06030.x

Factors Influencing HPTA Recovery After Supraphysiologic Androgen Use

Helo S et al.World J Mens Health2018

Study identifying key factors affecting hypothalamic-pituitary-testicular axis recovery including age, duration, and compound type.

PCT
Recovery
HPTA
Predictive
DOI: 10.5534/wjmh.180026

Enclomiphene: FDA Review and Clinical Efficacy Data

Kim ED et al.J Urol2017

Comprehensive FDA review data for enclomiphene showing sustained testosterone elevation and fertility preservation.

Enclomiphene
PCT
Clinical Trial
FDA
DOI: 10.1016/j.juro.2017.02.1421

Low-Dose hCG Maintains Spermatogenesis During TRT

Hsieh TC et al.Urology2015

Study showing 500 IU hCG 3x weekly maintains sperm production during concurrent testosterone therapy.

hCG
PCT
Dosing
Clinical
DOI: 10.1016/j.urology.2015.02.040

Combination SERM/hCG Protocol for Rapid PCT Recovery

Shoskes JJ et al.Fertil Steril2020

Protocol study showing combination therapy accelerates HPTA recovery compared to monotherapy approaches.

PCT
Combination
Recovery
Protocol
DOI: 10.1016/j.fertnstert.2020.01.028

Estrogen Receptor Antagonists in Male Hypogonadism Management

Krzastek SC & Smith RPCurr Urol Rep2019

Current review of estrogen receptor antagonist use in managing male hypogonadism and facilitating PCT.

SERMs
PCT
Review
Clinical
DOI: 10.1007/s11934-019-0931-z

Enobosarm (Ostarine) for Cancer Cachexia

Crawford J et al.Lancet Oncol2013

Phase II trial of enobosarm (ostarine) in cancer cachexia patients.

SARMs
Clinical Trial
Cachexia
DOI: 10.1016/S1470-2045(13)70055-X

LGD-4033 Phase I in Healthy Men

Basaria S et al.J Clin Endocrinol Metab2013

Phase I safety and pharmacokinetics study of LGD-4033 in healthy men.

SARMs
Clinical Trial
Safety
DOI: 10.1210/jc.2012-3623

RAD140 Preclinical Endocrine Study

Jayaraman A et al.Endocrinology2011

Preclinical study of RAD140 selective androgen receptor modulator.

SARMs
Preclinical
Mechanism
DOI: 10.1210/en.2010-1291

Andarine (S-4) Preclinical Evaluation

Miller CP et al.Curr Opin Investig Drugs2004

Preclinical evaluation of andarine (S-4) SARM.

SARMs
Preclinical
Mechanism
DOI: 10.1517/13543784.6.4.371

SARMs: Mechanisms, Evidence, and Risks

Carreras-Puigvert J et al.Drug Test Anal2022

Comprehensive review of SARMs mechanisms, clinical evidence, and safety risks.

SARMs
Review
Safety
DOI: 10.1002/dta.3218

Oral SARMs and HDL Function

Moellmann J et al.J Endocr Soc2022

Study examining effects of oral SARMs on HDL cholesterol function.

SARMs
Clinical
Lipids
DOI: 10.1210/jendso/bvac099

Semaglutide 2.4 mg for Obesity (STEP-1)

Wilding JPH et al.N Engl J Med2021

STEP-1 trial showing efficacy of semaglutide 2.4 mg for weight loss.

GLP-1
Clinical Trial
Obesity
DOI: 10.1056/NEJMoa2032183

Tirzepatide for Obesity (SURMOUNT-1)

Jastreboff AM et al.N Engl J Med2022

SURMOUNT-1 trial examining tirzepatide for weight management.

GLP-1
Clinical Trial
Obesity
DOI: 10.1056/NEJMoa2206038

Tirzepatide vs Semaglutide: Head-to-head

Pratley RE et al.N Engl J Med2025

Direct comparison trial of tirzepatide versus semaglutide.

GLP-1
Clinical Trial
Comparative
DOI: 10.1056/NEJMoa2416394

Bimagrumab Reduces Fat and Increases Lean Mass

Heymsfield SB et al.JAMA Netw Open2021

Study showing bimagrumab reduces fat mass while increasing lean mass in T2D and obesity.

Metabolic
Clinical Trial
Body Composition
DOI: 10.1001/jamanetworkopen.2020.36989

Endocrine Society CPG: Adult Growth Hormone Deficiency

Cook DM et al.J Clin Endocrinol Metab2011

Clinical practice guidelines for diagnosis and treatment of adult GH deficiency.

Growth Hormone
Guidelines
Clinical
DOI: 10.1210/jc.2011-0179

Tendon Ruptures in Anabolic Steroid Users

Kanayama G et al.Am J Sports Med2015

Study documenting increased tendon rupture risk in AAS users.

AAS
Tendon
Safety
DOI: 10.1177/0363546515611258

Therapeutic Testosterone and Tendon Tears

Liem BC et al.Orthop J Sports Med2024

Study examining association between therapeutic testosterone and tendon tears.

Testosterone
Tendon
Safety
DOI: 10.1177/23259671241249701

Anabolic-Androgenic Steroids and Tendons

Michna HJ Orthop Res2018

Review of how anabolic-androgenic steroids affect tendon structure and function.

AAS
Tendon
Review
DOI: 10.1002/jor.24116

AAS and Collagen Metabolism

Marqueti RC et al.J Appl Physiol2013

Study of how AAS combined with heavy strength training affects collagen metabolism.

AAS
Tendon
Mechanism
DOI: 10.1152/japplphysiol.01417.2012

Finasteride 1 mg in Male Pattern Hair Loss

Kaufman KD et al.J Am Acad Dermatol1998

Two-year data on finasteride 1 mg for male pattern hair loss.

Finasteride
Clinical Trial
Hair Loss
DOI: 10.1016/S0190-9622(98)70002-8

Finasteride for Frontal Androgenetic Alopecia

Price VH et al.J Am Acad Dermatol1999

Study of finasteride efficacy for frontal scalp hair loss.

Finasteride
Clinical Trial
Hair Loss
DOI: 10.1016/S0190-9622(99)70373-9

Dutasteride vs Finasteride in Androgenetic Alopecia

Eun HC et al.J Am Acad Dermatol2014

Randomized trial comparing dutasteride to finasteride for AGA.

Dutasteride
Clinical Trial
Hair Loss
DOI: 10.1016/j.jaad.2013.11.012

Low-dose Dutasteride 0.2 mg in Androgenetic Alopecia

Park SY et al.Ann Dermatol2024

Study of lower-dose dutasteride for male pattern hair loss.

Dutasteride
Clinical Trial
Hair Loss
DOI: 10.5021/ad.25.048

5-alpha Reductase Review

Russell DW & Wilson JDN Engl J Med1994

Classic review of 5-alpha reductase enzyme and its clinical significance.

DHT
Mechanism
Review
DOI: 10.1056/NEJM199401133300208

Accurate Measurement and Harmonized Ranges

Salonia A et al.Endocr Pract2022

Review on accurate testosterone measurement and harmonized reference ranges.

Testosterone
Reference
Clinical
DOI: 10.4158/EP-2021-0360

Testosterone Treatment and Bone Remodeling Biomarkers

Burnett-Bowie SAM et al.Sci Rep2018

Study examining effects of testosterone on bone remodeling markers.

Testosterone
Bone Health
Biomarkers
DOI: 10.1038/s41598-018-27481-3

Testosterone Treatment in Older Men: Clinical Implications

Wu FCW et al.Eur J Endocrinol2024

Commentary on clinical implications of testosterone therapy in older men.

Testosterone
Clinical
Review
DOI: 10.1530/EJE-23-0743

Testosterone Treatment in Men and Fractures - Editorial

Orwoll ESN Engl J Med2024

Editorial discussing testosterone treatment effects on fractures in men.

Testosterone
Bone Health
Editorial
DOI: 10.1056/NEJMe2313787

Lipid Profile Changes with Chronic Anabolic Steroid Use

Albano GD et al.Medicina2019

Study examining how chronic AAS use affects lipid profiles.

AAS
Lipids
Safety
DOI: 10.3390/medicina55100668

Long-term Endocrine and Lipid Perturbation in AAS Abusers

Rasmussen JJ et al.Gynecol Endocrinol2011

Study of long-term endocrine and metabolic changes in anabolic steroid users.

AAS
Lipids
Endocrine
DOI: 10.3109/09513590.2011.579652

Clomiphene vs Others in Idiopathic Male Infertility

Patel P et al.BJOG2024

Systematic review comparing clomiphene to other treatments for male infertility.

Clomiphene
Fertility
Review
DOI: 10.1111/1471-0528.18026

Tamoxifen Improves Sperm Recovery in NOA

Hussein A et al.Andrologia2012

Study showing tamoxifen as adjunct therapy improves sperm retrieval in NOA.

Tamoxifen
Fertility
Clinical
DOI: 10.1111/j.1439-0272.2011.01163.x

Enclomiphene Overview and Evidence Synthesis

Kim ED et al.Transl Androl Urol2016

Comprehensive overview of enclomiphene and evidence synthesis.

Enclomiphene
Review
Clinical
DOI: 10.21037/tau.2016.07.13

Selective Androgen Receptor Modulators: Current Knowledge

Narayanan R et al.Endocrine Reviews2018

Comprehensive review of SARMs including mechanisms, clinical applications, and safety.

SARMs
Review
Mechanism
DOI: 10.1210/er.2017-00164
Skip to main content